$1.16
-0.02-1.69%
At close: -
$1.16
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Standard BioTools Earnings Estimates, EPS & Revenue | NASDAQ:LAB | Benzinga
Standard BioTools reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.040
Quarterly Revenue Estimate
$45.60M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$174.43M
Analyze the earnings history of Standard BioTools using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LAB | Standard BioTools | -$0.27 | -$0.04 | — | — | $45.54M | $45.60M | — | — | 05/07/2025 | Get Alert |
| LAB | Standard BioTools | -$0.25 | -$0.03 | -$0.09 | -200.00% | $28.19M | $43.03M | $46.72M | 8.57% | 02/26/2025 | Get Alert |
| LAB | Standard BioTools | -$0.27 | -$0.09 | -$0.07 | 22.22% | $25.37M | $41.00M | $44.97M | 9.68% | 10/30/2024 | Get Alert |
| LAB | Standard BioTools | -$0.22 | — | -$0.12 | — | $27.67M | — | $37.20M | — | 07/31/2024 | Get Alert |
| LAB | Standard BioTools | -$0.21 | — | -$0.27 | — | $25.12M | — | $45.54M | — | 05/08/2024 | Get Alert |
| LAB | Standard BioTools | -$0.26 | — | -$0.25 | — | $27.02M | — | $28.19M | — | 02/28/2024 | Get Alert |
| LAB | Standard BioTools | -$0.26 | — | -$0.27 | — | $25.65M | — | $25.37M | — | 11/07/2023 | Get Alert |
| LAB | Standard BioTools | -$0.33 | — | -$0.22 | — | $18.78M | — | $27.67M | — | 08/08/2023 | Get Alert |
| LAB | Standard BioTools | -$0.25 | — | -$0.11 | — | $26.50M | — | $25.12M | — | 05/09/2023 | Get Alert |
| LAB | Standard BioTools | -$0.01 | — | -$0.19 | — | $38.27M | — | $27.02M | — | 02/14/2023 | Get Alert |
| LAB | Standard BioTools | -$0.07 | — | -$0.26 | — | $28.50M | $26.50M | $25.65M | -3.22% | 11/08/2022 | Get Alert |
| LAB | Standard BioTools | -$0.12 | — | -$0.33 | — | $31.02M | $26.50M | $18.78M | -29.14% | 08/08/2022 | Get Alert |
| LAB | Standard BioTools | -$0.15 | — | -$0.25 | — | $32.79M | $25.60M | $26.50M | 3.53% | 05/05/2022 | Get Alert |
| LAB | Standard BioTools | -$0.13 | -$0.28 | -$0.01 | 96.43% | $44.61M | $32.70M | $38.27M | 17.02% | 02/17/2022 | Get Alert |
| LAB | Standard BioTools | $0.03 | -$0.22 | -$0.07 | 68.18% | $39.86M | $30.00M | $28.50M | -4.99% | 11/08/2021 | Get Alert |
| LAB | Standard BioTools | -$0.07 | -$0.20 | -$0.12 | 40.00% | $26.06M | $30.57M | $31.02M | 1.47% | 08/05/2021 | Get Alert |
| LAB | Standard BioTools | -$0.13 | -$0.14 | -$0.15 | -7.14% | $27.62M | $31.97M | $32.79M | 2.58% | 05/06/2021 | Get Alert |
| LAB | Standard BioTools | -$0.03 | -$0.07 | -$0.13 | -85.71% | $32.44M | $50.72M | $44.61M | -12.05% | 02/10/2021 | Get Alert |
| LAB | Standard BioTools | -$0.09 | -$0.20 | $0.03 | 115.00% | $26.50M | $32.46M | $39.86M | 22.80% | 11/05/2020 | Get Alert |
| LAB | Standard BioTools | -$0.10 | -$0.23 | -$0.07 | 69.57% | $28.20M | $19.07M | $26.06M | 36.64% | 08/06/2020 | Get Alert |
| LAB | Standard BioTools | -$0.14 | -$0.15 | -$0.13 | 13.33% | $30.11M | $29.03M | $27.62M | -4.87% | 05/07/2020 | Get Alert |
Standard BioTools (LAB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $-0.09 | $-0.03 | -200.0 % |
| Q3 | 2024-10-30 | $-0.07 | $-0.09 | 22.2 % |
| Q4 | 2022-02-17 | $-0.01 | $-0.28 | 96.4 % |
| Q3 | 2021-11-08 | $-0.07 | $-0.22 | 68.2 % |
Standard BioTools (LAB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $46.72M | $43.03M | 8.57 % |
| Q3 | 2024-10-30 | $44.97M | $41.00M | 9.68 % |
| Q3 | 2022-11-08 | $25.65M | $26.50M | -3.22 % |
| Q2 | 2022-08-08 | $18.78M | $26.50M | -29.1 % |
FAQ
When is Standard BioTools (NASDAQ:LAB) reporting earnings?
Standard BioTools (LAB) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on February 26, 2025 for Q4.
What were the latest earnings per share (EPS) for Standard BioTools (NASDAQ:LAB)?
The Actual EPS was $-0.09, which missed the estimate of $-0.03.
What were Standard BioTools’s (NASDAQ:LAB) revenues?
The Actual Revenue was $46.7M, which beat the estimate of $43M.
Browse earnings estimates, EPS, and revenue on all stocks.